
Dr Péter Adorján has been appointed to the board of German rare disease firm Centogene and thereby extending its board …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

